Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid vs Pamidronate in high-risk bone metastatic breast cancer
NCT01907880Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Aug 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in breast cancer, sponsored by Ottawa Hospital Research Institute. Started Aug 2012; status: completed.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01907880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01907880.